LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer

Park, Youn C.; Ozguroglu, Mustafa; Kheoh, Thian; Todd, Mary Beth; Chi, Kim N.; Fizazi, Karim; Tran, Namphuong; Fein, Luis Enrique; Matsubara, Nobuaki; Antolin, Alfredo Rodriguez; Alekseev, Boris Y.; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew; De Porre, Peter

dc.contributor.author	Park, Youn C.
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Kheoh, Thian
dc.contributor.author	Todd, Mary Beth
dc.contributor.author	Chi, Kim N.
dc.contributor.author	Fizazi, Karim
dc.contributor.author	Tran, Namphuong
dc.contributor.author	Fein, Luis Enrique
dc.contributor.author	Matsubara, Nobuaki
dc.contributor.author	Antolin, Alfredo Rodriguez
dc.contributor.author	Alekseev, Boris Y.
dc.contributor.author	Ye, Dingwei
dc.contributor.author	Feyerabend, Susan
dc.contributor.author	Protheroe, Andrew
dc.contributor.author	De Porre, Peter
dc.date.accessioned	2021-03-05T10:42:59Z
dc.date.available	2021-03-05T10:42:59Z
dc.identifier.citation	Fizazi K., Tran N., Fein L. E. , Matsubara N., Antolin A. R. , Alekseev B. Y. , Ozguroglu M., Ye D., Feyerabend S., Protheroe A., et al., "LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer", 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35
dc.identifier.other	vv_1032021
dc.identifier.other	av_a4922c47-1c0f-4a6f-8dd5-54f2da46c5f9
dc.identifier.uri	http://hdl.handle.net/20.500.12627/110087
dc.identifier.uri	https://doi.org/10.1200/jco.2017.35.15_suppl.lba3
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	35
dc.contributor.firstauthorID	151429

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster